تعلن الشركة السعودية للصناعات الدوائية والمستلزمات الطبية (سبيماكو الدوائية) عن تنظ

A2070 SPIMACO-1.3 (-3.33 %)
1443/04/05 Wed Nov 10, 2021 08:02:21

The Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO) held its Q3 earnings call to discuss its interim financial results for the period ended 30-09-2021 (nine months) with representatives of investment companies and financial analysts

Share this: Facebook TwitterLinkedIn

Element List

Explanation

Announcement Detail

In line with its strategy to improve transparency and align to Investor Relations best practices, the Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO) organized on Tuesday, 9 November 2021, an earnings conference call meeting with representatives of investment companies and financial analysts to discuss its interim financial results for the period ended 30-09-2021. The executive management of SPIMACO, represented by the CEO and the CFO, presented a summary of the most significant financial indicators, achievements and challenges during the nine-month period of 2021. At the end of the presentation, the CEO and CFO answered the questions of the participants in the conference call. The link of the earnings call presentation: (http://spimaco.com.sa/img/Q3_2021.pdf)

The Capital Market Authority and the Saudi Stock Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.